期刊文献+

BANCR对甲状腺乳头状癌TSHR表达调控的研究进展 被引量:3

Research Progress of the regulation of BANCR on the expression of TSHR in thyroid papillary carcinoma
原文传递
导出
摘要 目的本文通过综述相关文献并分析甲状腺乳头状癌(PTC)发生发展过程中TSH/TSHR/c AMP和Ras/Raf/MEK/ERK(MAPK通路)两条信号通路,探讨了BRAF激活的长链非编码RNA(BANCR)对PTC组织中促甲状腺激素受体(TSHR)表达调节表达调控的意义。BANCR表达上调可能会使PTC组织中TSHR的表达降低,从而促进了PTC的发生发展,并可能影响患者预后。因此,明确BANCR对PTC组织TSHR表达调控的作用机制,有助于进一步明确PTC的发生机制,并可能会为PTC的临床诊断和治疗提供新的靶标。 We reviewed literatures and discussed the role of BANCR on the regulation of the expression of thyroid stimulating hormone receptor ( TSHR ) in thyroid papillary carcinoma by signaling pathways of TSH/TSHR/cAMP and Ras/Raf/MEK/ERK ( MAPK pathway ) in the development of papillary thyroid carcinoma ( PTC) .BANCR up-regulation would reduce TSHR expression in PTC , which might affect the prognosis of patients with PTC .As a consequence , it is helpful to further clarify the mechanism of PTC that explore the mechanism of regulation of the expression of TSHR in PTC by BANCR , which could provide a new target for the clinical diagnosis and treatment of PTC .
出处 《中华普外科手术学杂志(电子版)》 2016年第4期358-360,共3页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
关键词 甲状腺肿瘤 乳头状 受体 甲状腺激素 MAP激酶信号系统 Thyroid neoplasms Carcinoma,papillary Receptors,thyroid hormone MAP Kinase signaling system
作者简介 通讯作者:郑海涛,Email:zhenghaita01972@126.com
  • 相关文献

参考文献28

  • 1高明,李小龙.当今国内甲状腺癌发展趋势之面对[J].中华普通外科学文献(电子版),2014,8(1):1-3. 被引量:12
  • 2Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation [ J 1. J Surg Oncol, 2004,86 ( 1 ) : 44- 54.
  • 3Ceriani L, Treglia G, Paone G, et al. Unusual muscular metasta- ses from papillary thyroid carcinoma detected by fluorine-18-fluoro- deoxyglucose PET/MRI [ J 1. J Clin Endocrino| Metab, 2013,98 (6) :2208-2209.
  • 4张晨,霍倩,李翠珍,周志俊,吴庆.促甲状腺激素受体基因甲基化与甲状腺乳头状癌关联的Meta分析[J].中国全科医学,2013,16(28):3371-3375. 被引量:6
  • 5Milas M, Shin J, Gupta M, et al. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples [ J ]. Ann Surg, 2010,252 ( 4 ) : 643- 651.
  • 6Matsumoto H, Sakamoto A, Fujiwara M, et al. Decreased expres- sion of the thyroid-stimulating hormone.receptor in poorly-differen- tiated carcinoma of the thyroid [ J 1. Oncol Rep, 2008,19 ( 6 ) : 1405-1411.
  • 7Xing M, Usadel H, Cohen Y, et al. Methylation of the thyroid- stimulating hormone receptor gene in epithelial thyroid tumors: amarker of malignancy and a cause of gene silencing [ J ]. Cancer Res,2003,63 (9) :2316-2321.
  • 8Khan MS, Pandith AA, Masoodi SR, et al. Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status[J]. Endocrine,2014,47(2) :449-455.
  • 9Garnett M J, Marais R. Guilty as charged: B-RAF is a human on- cogene[ J]. Cancer Ce11,2004,6(4) :313-319.
  • 10Orim F, Bychkov A, Shimanmra M, et al. Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAF(V600E)-induced thyroid tumors in a mouse model [ J]. Thyroid,2014,24(3 ) :502-510.

二级参考文献54

  • 1Lee J, Park JH, Lee CR, et al. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching[J]. Thyroid, 2013, 23(11): 1408-1415.
  • 2Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension[J]. Thyroid, 2012, 22(11): 1144-1152.
  • 3Berteaux N, Lottin S, Monte D, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2FI[J]. J Biol Chem,2005,280(33) :29625-29636.
  • 4Okamoto K, Morison IM, Taniguchi T, et al. Epigenetie changes at the insulin-like growth factor II/H19 locus in developing kidney is an ear- ly event in Wilms tumorigenesis[J]. Proc Natl Acad Sci U S A ,1997, 94(10) :5367-5371.
  • 5Smits G, Mungall AJ, Griffiths-Jones S, et al. Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians [ J ]. Nat Genet ,2008,40 ( 8 ) :971-976.
  • 6Andreeva AV, Kutuzov MA. Cadherin 13 in cancer[ J]. Genes Chro- mosomes Cancer,2010,49 (9) :775-790.
  • 7Pelizzo MR, Dobrinja C, Casal Ide E, et al. The role of BRAF (V6OOE) mutation as poor prognostic factor for the outcome of pa- tients with intrathyroid papillary thyroid carcinoma [ J ]. Biomed Pharmacother,2014,68 (4) :413-417.
  • 8Mekel M, Nueera C, Hodin RA, et al. Surgical implications of B-RAFv6E mutation in fine-needle aspiration of thyroid nodules[ J]. Am J Surg,2010,200( 1 ) : 136-143.
  • 9Chakravarty D, Santos E, Ryder M, et al. Small-molecule MAPK inhibitom restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation [ J ]. J Clin Invest, 2011,121 (12) :4700-4711.
  • 10Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oneogenic mutation of B-RAF [J]. Ce11,2004,116(6) :855-867.

共引文献86

同被引文献16

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部